SEHK:2367Personal Products
Assessing Giant Biogene Holding (SEHK:2367) Valuation After Approving Final And Special Dividends
Giant Biogene Holding (SEHK:2367) has put shareholder returns in focus after its AGM on 28 May 2026, approving both a final dividend and a separate special dividend for the 2025 financial year.
See our latest analysis for Giant Biogene Holding.
The dividend approvals come after a tough period for investors, with the stock posting a 1-year total shareholder return decline of 51.31% and a year to date share price return of 18.82% lower. However, the latest 1 day share price return of 1.46%...